Home
    • Plans Blog Contact
    Orthopediatrics Corp logo

    Orthopediatrics Corp

    KIDS
    Last price US$18.84
    Market cap US$481.9m
    12M price change -17.31%
    Loading the 12-month Mave Thesis and 1-month news signal

    Industry and sector peers, plus broader research alternatives

    View comparison
    AmerisourceBergenABC Industry peer Insulet CorporationPODD Industry peer NuVasive IncNUVA Industry peer Zoetis IncZTS Sector peer
    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    Orthopediatrics Corp Overview

    Industry: Healthcare Equipment & Supplies

    Sector: Healthcare

    OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana. OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis proc Read More

    Mavefund brings filings, fundamentals, valuation, price history and news for Orthopediatrics Corp into one research view. The sections below show what strengthens or weakens the research case.

    Score

    Reported Results

    What the company reported, with filing details kept small.

    Filed Apr 30, 2026

    Quarterly result summary

    Revenue was $15.4M (+12% YoY). Net loss was -$10.7M (from $10.7M). Adjusted EBITDA was $2.2M.

    Revenue $15.4M +12% YoY
    Net loss -$10.7M from $10.7M
    Adjusted EBITDA $2.2M reported
    Cash $50.9M reported

    What changed

    • Revenue +12% YoY to $15.4M.
    • Net loss was -$10.7M (from $10.7M).

    Guidance / outlook

    No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.

    Earnings release Open filing

    Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

    Other recent earnings materials
    SEC filing 10-Q May 01, 2026 SEC filing 8-K Apr 30, 2026 SEC filing 10-K Mar 04, 2026 SEC filing 8-K Feb 26, 2026 Earnings release Earnings release Feb 26, 2026 SEC filing 8-K Jan 12, 2026 SEC filing 10-Q Oct 29, 2025 Earnings release Earnings release Oct 28, 2025 SEC filing 8-K Oct 28, 2025 SEC filing 8-K Oct 09, 2025 Earnings release Earnings release Oct 09, 2025

    Prediction-grade evidence

    Recent News

    Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

    Earnings Per Share

    Score 2.00/5
    Orthopediatrics Corp earns a low score, as its Earnings Per Share (EPS) has not shown continuous growth over the last six years. Notable counterparts in the sector with high scores includes Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    In Healthcare Equipment & Supplies industry , AmerisourceBergen , Insulet Corporation , NuVasive Inc are companies with high ratings.

    Return on Equity

    Score 3.06/5
    Orthopediatrics Corp stands out with a superior score in the Return on Equity (ROE) section, surpassing the sector median value and showcasing its strong performance in this metric. The top companies in the same sector include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    Orthopediatr... KIDS US$481.9m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Net Margin

    Score 2.05/5
    Orthopediatrics Corp olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    Orthopediatr... KIDS US$481.9m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Share Buyback

    In Healthcare Equipment & Supplies industry , AmerisourceBergen , Insulet Corporation , NuVasive Inc are companies with high ratings.

    Leverage

    Score 2.99/5
    Orthopediatrics Corp attains a commendable score in the category due to its lower leverage ratio over the past six years in comparison to the sector median value. Additionally, other notable companies in the same sector, such as Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc , also exhibit high scores.
    Orthopediatr... KIDS US$481.9m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    Verified SEC statements load when this section enters view.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    Orthopediatrics Corp logo

    Orthopediatrics Corp

    US$18.84

    US$481.9m

    -1.83%

    -17.31%